AMR vs South Korea: Hypertension: effective treatment coverage (controlled hypertension)
AMR
37.3%
in 2019
South Korea
55.4%
in 2019
AMR rank
2nd
South Korea rank
2nd
Hypertension: effective treatment coverage (controlled hypertension) over time
- AMR
- South Korea
How they compare
South Korea currently reports 55.4% against 37.3% in AMR, a difference of 18.1%.
That makes South Korea's figure about 1.5 times AMR's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was AMR ahead.
AMR ranks 2nd and South Korea ranks 2nd of 17 groups.
Across the 3 decades both report, AMR averaged higher in 2 and South Korea in 1.
Head to head by decade
| Decade | AMR | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 17.6% | 7.4% | 10.1% | AMR |
| 2000s | 27.4% | 25.2% | 2.2% | AMR |
| 2010s | 35.8% | 48.4% | 12.6% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), AMR or South Korea?
- South Korea, at 55.4% against 37.3% in AMR as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between AMR and South Korea?
- 18.1%, with South Korea ahead.
- How many years of comparable data are there for AMR and South Korea?
- 30 years are reported by both, from 1990 to 2019.
- How do AMR and South Korea rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- AMR ranks 2nd and South Korea ranks 2nd of 17 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.